Diagnostic antibodies and antigens for Chronic atrophic gastritis (CAG) testing: Gastrin 17 (G17)

Metabolites/Chemicals-IVD

Alzheimer’s Disease (AD) Diagnostics

Bone metabolism & osteoporosis Diagnostics

Monkeypox virus (MPV) antigen & antibody

SARS-CoV-2 Solution

Bovine/Cattle Diagnostics Solution

Diagnostic Cancer

Diagnostic Infectious Disease

Diagnostic Inflammation/ Autoimmune/ Inflammatory Disease

Diagnostic Cardiovascular Disease

Diagnostic Liver Diseases

Diagnostic Lung Injury

Diagnostic Kidney Function (renal damages)

Diagnostic Gastric Disease

Diagnostic Thyroid Diseases

Diagnostic Bowel Disease

Diagnostic Fertility

Diagnostic Diabetes Diseases

Diagnostic Metabolic Disease

Diagnostic Hormone Disorders

Diagnostic Vitamin Deficiency

Diagnostic Fibrinogen Disorders

Diagnostic Neurodegenerative Diseases

Diagnostic Epilepsy

Diagnostic Pain

Diagnostic Multiple Disease

Diagnostic Biology

Diagnostic antibodies and antigens for Companion Animal disease testing

● Dog/Canine

● Cat/Feline

● Rabbit

Diagnostic antibodies and antigens for Swine disease testing

Diagnostic antibodies and antigens for Avian disease testing

Diagnostic antibodies and antigens for Multiple animal disease testing

Diagnostic antibodies and antigens for Ruminant disease testing

● Bovines/Cattle

● Ovines/Sheep

● Caprine/Goat

● Deer

Diagnostic antibodies and antigens for infectious and non-infectious  Equine/Horse disease testing

Diagnostic antibodies and antigens for Fish disease testing

Antibiotics

Food Safety

Agricultural

Allergen

Mycotoxins

Drugs of Abuse

Toxic Heavy Metal

Hormones

Chemicals

Vitamins

Amino Acids

Cell Therapy and Gene Therapy News

Gene Therapy Technical Articles

Technical Resources

How to order

How to pay

Product FAQs

SOCAIL MEDIA

Chronic atrophic gastritis (CAG) with intestinal metaplasia is recognized to be a precancerous lesion that can evolve toward low- and high-grade intraepithelial lesions and gastric cancer. CAG is characterized by loss of gastric glands and can be evaluated endoscopically, histologically and serologically. Therefore, its early detection is a priority in preventing gastric cancer. Hence, biomarkers such as Gastrin-17 (G-17) and so on have been developed to detect the chronic atrophic gastritis at an early stage to significantly reduce the gastric cancer.

GENEMEDI developed the Gastrin-17 (G-17) antigens and antibodies for the diagnosis of chronic atrophic gastritis based on ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.

Genemedi supplies antibodies and antigens for Chronic atrophic gastritis (CAG) testing for a wide selection of choices (please see below).

Cat No. Antibody/Antigen Name Expression platform Isotypes Bioactivity validation Order
GMP-SMT-G17-Ag; GMP-SMT-G17-Ab Antigen: BSA-Gastrin 17 (G17); Antibody: Anti-Gastrin 17 (G17) mouse monoclonal antibody(mAb) Antigen: Synthetic; Antibody:  Hybridoma Antigen: NA; Antibody: Mouse IgG Antigen: Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT Antibody: human Gastrin 17 (G17) binding, Competitive immunoassay validation (Competitive ELISA) in G17 level test and Chronic atrophic gastritis (CAG) evaluation. Picture loading failed.